| Year |
Citation |
Score |
| 2024 |
Bates JT, Lirette ST, Farmer AP, Bierdeman MA, Seyfarth KB, Ederer DR, Montgomery DD, Burnett GC, Pham AT, Marshall GD. Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection. Human Vaccines & Immunotherapeutics. 20: 2308375. PMID 38361363 DOI: 10.1080/21645515.2024.2308375 |
0.327 |
|
| 2022 |
Bates JT, Farmer AP, Bierdeman MA, Ederer DR, Carney LS, Montgomery DD, Lirette ST, Marshall GD. IgG Antibody Response to the Pfizer BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers with Healthy Weight, Overweight, and Obesity. Vaccines. 10. PMID 35455261 DOI: 10.3390/vaccines10040512 |
0.328 |
|
| 2022 |
Pramanik A, Sharma PC, Patibandla S, Gao Y, Ruppa-Kasani V, Goli J, Kumar A, Chatterjee A, Sinha SS, Bates JT, Bierdeman MA, Tandon R, Ray PC. Blocking SARS-CoV-2 Delta Variant (B.1.617.2) Spike Protein Receptor-Binding Domain Binding with the ACE2 Receptor of the Host Cell and Inhibiting Virus Infections Using Human Host Defense Peptide-Conjugated Graphene Quantum Dots. Acs Omega. 7: 8150-8157. PMID 35252734 DOI: 10.1021/acsomega.2c00113 |
0.323 |
|
| 2021 |
Shalaby A, Laharwani H, Bates JT, Kyle PB. Efficacy of POC Antibody Assays after COVID-19 Infection and Potential Utility for "Immunity Passports". Laboratory Medicine. PMID 34791323 DOI: 10.1093/labmed/lmab093 |
0.307 |
|
| 2021 |
Mitra D, Hasan MH, Bates JT, Bierdeman MA, Ederer DR, Parmar RC, Fassero LA, Liang Q, Qiu H, Tiwari V, Zhang F, Linhardt RJ, Sharp JS, Wang L, Tandon R. The degree of polymerization and sulfation patterns in heparan sulfate are critical determinants of cytomegalovirus entry into host cells. Plos Pathogens. 17: e1009803. PMID 34352038 DOI: 10.1371/journal.ppat.1009803 |
0.35 |
|
| 2021 |
Yan L, Song Y, Xia K, He P, Zhang F, Chen S, Pouliot R, Weiss DJ, Tandon R, Bates JT, Ederer DR, Mitra D, Sharma P, Davis A, Linhardt RJ. Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus. Carbohydrate Polymers. 260: 117797. PMID 33712145 DOI: 10.1016/j.carbpol.2021.117797 |
0.311 |
|
| 2020 |
Tandon R, Mitra D, Sharma P, McCandless MG, Stray SJ, Bates JT, Marshall GD. Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein. Scientific Reports. 10: 19076. PMID 33154514 DOI: 10.1038/s41598-020-76135-w |
0.307 |
|
| 2020 |
Sesterhenn F, Yang C, Bonet J, Cramer JT, Wen X, Wang Y, Chiang CI, Abriata LA, Kucharska I, Castoro G, Vollers SS, Galloux M, Dheilly E, Rosset S, Corthésy P, ... ... Bates JT, et al. De novo protein design enables the precise induction of RSV-neutralizing antibodies. Science (New York, N.Y.). 368. PMID 32409444 DOI: 10.1126/Science.Aay5051 |
0.53 |
|
| 2017 |
Wen X, Mousa JJ, Bates JT, Lamb RA, Crowe JE, Jardetzky TS. Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus. Nature Microbiology. 2: 16272. PMID 28134915 DOI: 10.1038/Nmicrobiol.2016.272 |
0.779 |
|
| 2016 |
Mousa JJ, Sauer MF, Sevy AM, Finn JA, Bates JT, Alvarado G, King HG, Loerinc LB, Fong RH, Doranz BJ, Correia BE, Kalyuzhniy O, Wen X, Jardetzky TS, Schief WR, et al. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein. Proceedings of the National Academy of Sciences of the United States of America. PMID 27791117 DOI: 10.1073/Pnas.1609449113 |
0.504 |
|
| 2016 |
Bates JT, Pickens JA, Schuster JE, Johnson M, Tollefson SJ, Williams JV, Davis NL, Johnston RE, Schultz-Darken N, Slaughter JC, Smith-House F, Crowe JE. Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates. Vaccine. PMID 26772634 DOI: 10.1016/J.Vaccine.2015.12.045 |
0.707 |
|
| 2015 |
Galliher-Beckley A, Li X, Bates JT, Madera R, Waters A, Nietfeld J, Henningson J, He D, Feng W, Chen R, Shi J. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20. Vaccine. 33: 3518-25. PMID 26049004 DOI: 10.1016/J.Vaccine.2015.05.058 |
0.429 |
|
| 2014 |
Bates JT, Keefer CJ, Slaughter JC, Kulp DW, Schief WR, Crowe JE. Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein. Virology. 454: 139-44. PMID 24725940 DOI: 10.1016/J.Virol.2014.02.010 |
0.784 |
|
| 2014 |
Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, et al. Proof of principle for epitope-focused vaccine design. Nature. 507: 201-6. PMID 24499818 DOI: 10.1038/Nature12966 |
0.553 |
|
| 2013 |
Bates JT, Keefer CJ, Utley TJ, Correia BE, Schief WR, Crowe JE. Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency. Journal of Immunology (Baltimore, Md. : 1950). 190: 3732-9. PMID 23455501 DOI: 10.4049/Jimmunol.1202964 |
0.734 |
|
| 2013 |
Zeitlin L, Bohorov O, Bohorova N, Hiatt A, Kim DH, Pauly MH, Velasco J, Whaley KJ, Barnard DL, Bates JT, Crowe JE, Piedra PA, Gilbert BE. Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model Mabs. 5: 263-269. PMID 23396091 DOI: 10.4161/Mabs.23281 |
0.514 |
|
| 2011 |
Bates JT, Graff AH, Phipps JP, Grayson JM, Mizel SB. Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88. Journal of Immunology (Baltimore, Md. : 1950). 186: 6255-62. PMID 21515787 DOI: 10.4049/Jimmunol.1001855 |
0.322 |
|
| 2010 |
Mizel SB, Bates JT. Flagellin as an adjuvant: cellular mechanisms and potential. Journal of Immunology (Baltimore, Md. : 1950). 185: 5677-82. PMID 21048152 DOI: 10.4049/Jimmunol.1002156 |
0.349 |
|
| 2001 |
Rimmelzwaan GF, Nieuwkoop N, Brandenburg A, Sutter G, Beyer WE, Maher D, Bates J, Osterhaus AD. A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. Vaccine. 19: 1180-7. PMID 11137255 DOI: 10.1016/S0264-410X(00)00310-8 |
0.327 |
|
| 1998 |
Deliyannis G, Jackson DC, Dyer W, Bates J, Coulter A, Harling-McNabb L, Brown LE. Immunopotentiation of humoral and cellular responses to inactivated influenza vaccines by two different adjuvants with potential for human use. Vaccine. 16: 2058-68. PMID 9796065 DOI: 10.1016/S0264-410X(98)00080-2 |
0.343 |
|
| 1998 |
Coulter A, Wong TY, Drane D, Bates J, Macfarlan R, Cox J. Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes (Iscoms) and oil-in-water vaccines. Vaccine. 16: 1243-53. PMID 9682385 DOI: 10.1016/S0264-410X(98)80125-4 |
0.331 |
|
| 1984 |
Mumford JA, Bates J. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus Veterinary Record. 114: 375-381. PMID 6328729 DOI: 10.1136/VR.114.15.375 |
0.323 |
|
| Show low-probability matches. |